Information updates

NPS MedicineWise Immunoglobulin Consortium

16 December 2019: 

A new grant will fund a project which will increase national efforts to improve health outcomes for patients prescribed immunoglobulin products. This project involves the National Prescribing Service (NPS) MedicineWise and a consortium of health organisations, including ASCIA and SHPA (Society of Hospital Pharmacists of Australia).  The grant was awarded to NPS MedicineWise under the Australian Government’s Value in Prescribing program (Immunoglobulin Products stream). 

The funding will see NPS MedicineWise working with the National Blood Authority and  stakeholders to develop and deliver educational resources, tools and interventions to support clinicians in optimising the use of precious immunoglobulin products, as well as to educate consumers on the role of these products. The project may expand to include other consortium partners and is being managed in collaboration with the Australian Government Department of Health and the National Blood Authority.

The substantial annual growth in immunoglobulin use, both in Australia and internationally, together with the relatively high cost of immunoglobulin products and the potential for supply shortages mean that good governance, education and quality improvement are essential to ensure that use remains appropriate, consistent and evidence-based.

This project supports a viable and sustainable immunoglobulin prescribing system by promoting appropriate use of these valuable resources.

pdfNPS MedicineWise Immunoglobulin Consortium Media Release Dec 2019107.35 KB 

Mod ASCIA Member
Donate to AIFA
go to NAS website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.